Recent developments with TransCode Therapeutics Inc (RNAZ) have led to the company’s beta value being reach 1.54 cents.
TransCode Therapeutics Inc (NASDAQ: RNAZ) kicked off on Monday, up 11.00% from the previous trading day, before settling in for the closing price of $0.38.